Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.
6 hours ago
0
62
Most adolescent electronic cigarette users do not use cessation resources in their attempts to quit, according to a study published online Oct. 2 in Pediatrics.
Oct 3, 2023
0
8
Imagine a patient with a rare genetic disorder that makes their arms and legs have imprecise and slow movements. For years, the patient has faced serious restrictions in day-to-day life. They tried several treatments, but ...
Aug 12, 2022
0
2
COVID-19 has put a spotlight on Canada's pandemic preparedness, and led some experts and leaders to call for a new public agency that would be in charge of domestic vaccine production to increase self-sufficiency.
Jul 28, 2022
0
3
As the lone laboratory manufacturing a licensed vaccine against monkeypox, Danish company Bavarian Nordic has seen its order book fill up as the usually rare disease spreads around the world.
Jun 23, 2022
0
3
Today, treatment methods are available for cancer that complement each other. Radiation therapy is frequently used, and can be combined with surgery and chemotherapy, for example. Although treatment with ionizing radiation ...
Mar 11, 2022
0
41
Swiss pharmaceuticals giant Novartis said Thursday it has signed a new agreement to farm out some of its production facilities and help manufacture much-needed doses of the Pfizer-BioNTech coronavirus vaccine.
Oct 21, 2021
0
6
Franco-Austrian biotech lab Valneva announced Monday positive results from clinical trials of its COVID vaccine candidate, a month after the UK government terminated a supply deal with the company.
Oct 18, 2021
1
40
Nuclear therapy and molecular imaging are widely used at hospitals for new promising medical procedures. They can drastically improve the outcome for many medical conditions and in particular enable the treatment of disseminated ...
Sep 24, 2021
0
11
The British government has terminated a supply deal for a potential COVID jab being developed by French-Austrian biotech laboratory Valneva, the firm said on Monday.
Sep 13, 2021
0
3
